Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Insight Partners in connection with its investment by participation in a MSEK 190 investment round in Insurely
Mandate

Vinge has advised Insight Partners in connection with its investment by participation in a MSEK 190 investment round in Insurely

March 08, 2022 Employment and Benefits Insurance Law IT, Telecommunications and Outsourcing M&A Corporate Crime & Compliance Financial Regulatory Intellectual Property

Vinge has advised Insight Partners in connection with its investment by participation in a MSEK 190 investment round in Insurely. Insurely offers a digital platform which gives insurance policyholders easy access to an overview of their insurance policies.

Vinge’s team consisted of Christina Kokko, Johan Larsson, Isabelle Wållgren and Nando Basic (M&A), Viveka Classon and Elin Samara (Insurance regulatory), Fredrika Hjelmberg (IT), Nicklas Thorgerzon (GDPR), Elin Broman (Employment), Axel Lennartsson (IPR), Tove Tullberg (Compliance) and Sara Dahlros Sköld (VDR).

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026